ACPL2 Antibody
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


ACPL2 Antibody
Description:
ACPL2 Antibody_x000D_ Catalog number: B2015861_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 50 µg_x000D_ Molecular Weight or Concentration: 55 kDa_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: 2-8° C_x000D_ Keywords: ACPL2 Antibody_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Li L, Rousseau J, Jaraquemada-Peláez MG, Wang X, Robertson A, Radchenko V, Schaffer P, Lin KS, Bénard F, Orvig C. (225)Ac-H(4)py4pa for Targeted Alpha Therapy Bioconjug Chem. 2021 Jul 21;32(7):1348-1363._x000D_ 2: Spreckelmeyer S, Ramogida CF, Rousseau J, Arane K, Bratanovic I, Colpo N, Jermilova U, Dias GM, Dude I, Jaraquemada-Peláez MG, Bénard F, Schaffer P, Orvig C. p-NO(2)-Bn-H(4)neunpa and H(4)neunpa-Trastuzumab: Bifunctional Chelator for Radiometalpharmaceuticals and (111)In Immuno-Single Photon Emission Computed Tomography Imaging Bioconjug Chem. 2017 Aug 16;28(8):2145-2159._x000D_ 3: Southcott L, Wharton L, Rousseau J, Merkens H, Yang H, Bénard F, Orvig C. Trastuzumab-conjugated oxine-based ligand for [(89)Zr]Zr(4+) immunoPET J Inorg Biochem. 2022 Oct;235:111936._x000D_ 4: Gantner F, Sakai K, Tusche MW, Cruikshank WW, Center DM, Bacon KB. Histamine h(4) and h(2) receptors control histamine-induced interleukin-16 release from human CD8(+) T cells J Pharmacol Exp Ther. 2002 Oct;303(1):300-7._x000D_ 5: Gomez-Bañuelos E, Yu Y, Li J, Cashman KS, Paz M, Trejo-Zambrano MI, Bugrovsky R, Wang Y, Chida AS, Sherman-Baust CA, Ferris DP, Goldman DW, Darrah E, Petri M, Sanz I, Andrade F. Affinity maturation generates pathogenic antibodies with dual reactivity to DNase1L3 and dsDNA in systemic lupus erythematosus Nat Commun. 2023 Mar 20;14(1):1388._x000D_ 6: Butler JE, Sun J, Wertz N, Sinkora M. Antibody repertoire development in swine Dev Comp Immunol. 2006;30(1-2):199-221._x000D_ 7: Price EW, Zeglis BM, Cawthray JF, Ramogida CF, Ramos N, Lewis JS, Adam MJ, Orvig C. H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy J Am Chem Soc. 2013 Aug 28;135(34):12707-21._x000D_ 8: Suwa E, Yamaura K, Oda M, Namiki T, Ueno K. Histamine H(4) receptor antagonist reduces dermal inflammation and pruritus in a hapten-induced experimental model Eur J Pharmacol. 2011 Sep 30;667(1-3):383-8._x000D_ 9: Chapman CJ, Wright D, Stevenson FK. Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis Leuk Lymphoma. 1998 Jul;30(3-4):257-67._x000D_ 10: Tsay GJ, Zouali M. The Interplay Between Innate-Like B Cells and Other Cell Types in Autoimmunity Front Immunol. 2018 May 16;9:1064. _x000D_ _x000D_ Products Related to ACPL2 Antibody can be found at AntibodiesShort Description:
Catalog Number: B2015861 (50 µg)Weight:
0.15Length:
2Width:
0.5Height:
0.5Height :
0.5CAS Number:
9007-83-4
